CN105494742A - 治疗慢性胃炎的养生中药茶饮品及制备方法 - Google Patents
治疗慢性胃炎的养生中药茶饮品及制备方法 Download PDFInfo
- Publication number
- CN105494742A CN105494742A CN201510959567.6A CN201510959567A CN105494742A CN 105494742 A CN105494742 A CN 105494742A CN 201510959567 A CN201510959567 A CN 201510959567A CN 105494742 A CN105494742 A CN 105494742A
- Authority
- CN
- China
- Prior art keywords
- parts
- chinese medicine
- traditional chinese
- health
- tea drink
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000003814 drug Substances 0.000 title claims abstract description 37
- 208000007882 Gastritis Diseases 0.000 title claims abstract description 15
- 238000002360 preparation method Methods 0.000 title claims abstract description 11
- 208000023652 chronic gastritis Diseases 0.000 title claims abstract description 9
- 238000012423 maintenance Methods 0.000 title abstract 4
- 241001122767 Theaceae Species 0.000 title 1
- 235000013616 tea Nutrition 0.000 claims abstract description 34
- 244000269722 Thea sinensis Species 0.000 claims abstract description 27
- 239000002994 raw material Substances 0.000 claims abstract description 16
- 235000005187 Taraxacum officinale ssp. officinale Nutrition 0.000 claims abstract description 14
- 235000003145 Hippophae rhamnoides Nutrition 0.000 claims abstract description 11
- 235000009569 green tea Nutrition 0.000 claims abstract description 10
- 240000000950 Hippophae rhamnoides Species 0.000 claims abstract 4
- 241000245665 Taraxacum Species 0.000 claims description 10
- 241001647745 Banksia Species 0.000 claims description 7
- 241000220317 Rosa Species 0.000 claims description 7
- 238000004659 sterilization and disinfection Methods 0.000 claims description 4
- 238000010411 cooking Methods 0.000 claims description 3
- 238000002156 mixing Methods 0.000 claims description 3
- 230000000694 effects Effects 0.000 abstract description 23
- 208000002193 Pain Diseases 0.000 abstract description 10
- 201000006549 dyspepsia Diseases 0.000 abstract description 8
- 230000001737 promoting effect Effects 0.000 abstract description 7
- 230000004087 circulation Effects 0.000 abstract description 6
- 230000002496 gastric effect Effects 0.000 abstract description 6
- 240000001949 Taraxacum officinale Species 0.000 abstract description 5
- 208000000718 duodenal ulcer Diseases 0.000 abstract description 5
- 208000007107 Stomach Ulcer Diseases 0.000 abstract description 4
- 201000010099 disease Diseases 0.000 abstract description 4
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract description 4
- 230000001105 regulatory effect Effects 0.000 abstract description 2
- 230000008961 swelling Effects 0.000 abstract description 2
- 241000675108 Citrus tangerina Species 0.000 abstract 2
- 244000272264 Saussurea lappa Species 0.000 abstract 2
- 235000006784 Saussurea lappa Nutrition 0.000 abstract 2
- 230000013872 defecation Effects 0.000 abstract 1
- 239000000843 powder Substances 0.000 abstract 1
- 231100000331 toxic Toxicity 0.000 abstract 1
- 230000002588 toxic effect Effects 0.000 abstract 1
- 241000229143 Hippophae Species 0.000 description 9
- BAHMQESJBKGPTE-UHFFFAOYSA-N 1,5,8-trimethyl-3a,4-dihydroazuleno[6,5-b]furan-2,6-dione Chemical compound C1C2OC(=O)C(C)=C2C=C2C(C)=CC(=O)C2=C1C BAHMQESJBKGPTE-UHFFFAOYSA-N 0.000 description 8
- 206010011224 Cough Diseases 0.000 description 4
- 206010062717 Increased upper airway secretion Diseases 0.000 description 4
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 4
- 208000026435 phlegm Diseases 0.000 description 4
- 206010012735 Diarrhoea Diseases 0.000 description 3
- LGJMUZUPVCAVPU-UHFFFAOYSA-N beta-Sitostanol Natural products C1CC2CC(O)CCC2(C)C2C1C1CCC(C(C)CCC(CC)C(C)C)C1(C)CC2 LGJMUZUPVCAVPU-UHFFFAOYSA-N 0.000 description 3
- 229960001231 choline Drugs 0.000 description 3
- OEYIOHPDSNJKLS-UHFFFAOYSA-N choline Chemical compound C[N+](C)(C)CCO OEYIOHPDSNJKLS-UHFFFAOYSA-N 0.000 description 3
- 238000001723 curing Methods 0.000 description 3
- 229940079593 drug Drugs 0.000 description 3
- 208000001848 dysentery Diseases 0.000 description 3
- 235000013305 food Nutrition 0.000 description 3
- 201000005917 gastric ulcer Diseases 0.000 description 3
- 238000000034 method Methods 0.000 description 3
- 230000000144 pharmacologic effect Effects 0.000 description 3
- XWMMEBCFHUKHEX-MRTCRTFGSA-N (+)-Taraxasterol Chemical compound C([C@@]12C)C[C@H](O)C(C)(C)[C@@H]1CC[C@]1(C)[C@@H]2CC[C@H]2[C@@H]3[C@H](C)C(=C)CC[C@]3(C)CC[C@]21C XWMMEBCFHUKHEX-MRTCRTFGSA-N 0.000 description 2
- OILXMJHPFNGGTO-UHFFFAOYSA-N (22E)-(24xi)-24-methylcholesta-5,22-dien-3beta-ol Natural products C1C=C2CC(O)CCC2(C)C2C1C1CCC(C(C)C=CC(C)C(C)C)C1(C)CC2 OILXMJHPFNGGTO-UHFFFAOYSA-N 0.000 description 2
- QMKPCZNFLUQTJZ-UHFFFAOYSA-N (4aR)-10c-Hydroxy-1t.2c.4ar.6at.6bc.9.9.12ac-octamethyl-(8atH.12btH.14acH.14btH)-docosahydro-picen Natural products CC1CCC2(C)CCC3(C)C(CCC4C5(C)CCC(O)C(C)(C)C5CCC34C)C2C1C QMKPCZNFLUQTJZ-UHFFFAOYSA-N 0.000 description 2
- OQMZNAMGEHIHNN-UHFFFAOYSA-N 7-Dehydrostigmasterol Natural products C1C(O)CCC2(C)C(CCC3(C(C(C)C=CC(CC)C(C)C)CCC33)C)C3=CC=C21 OQMZNAMGEHIHNN-UHFFFAOYSA-N 0.000 description 2
- 206010000060 Abdominal distension Diseases 0.000 description 2
- 206010002383 Angina Pectoris Diseases 0.000 description 2
- 206010007247 Carbuncle Diseases 0.000 description 2
- 206010010741 Conjunctivitis Diseases 0.000 description 2
- 206010017553 Furuncle Diseases 0.000 description 2
- DATAGRPVKZEWHA-YFKPBYRVSA-N N(5)-ethyl-L-glutamine Chemical compound CCNC(=O)CC[C@H]([NH3+])C([O-])=O DATAGRPVKZEWHA-YFKPBYRVSA-N 0.000 description 2
- OBIOZWXPDBWYHB-UHFFFAOYSA-N Nobiletin Natural products C1=CC(OC)=CC=C1C1=C(OC)C(=O)C2=C(OC)C(OC)=C(OC)C(OC)=C2O1 OBIOZWXPDBWYHB-UHFFFAOYSA-N 0.000 description 2
- 206010036790 Productive cough Diseases 0.000 description 2
- HZYXFRGVBOPPNZ-UHFFFAOYSA-N UNPD88870 Natural products C1C=C2CC(O)CCC2(C)C2C1C1CCC(C(C)=CCC(CC)C(C)C)C1(C)CC2 HZYXFRGVBOPPNZ-UHFFFAOYSA-N 0.000 description 2
- 208000019790 abdominal distention Diseases 0.000 description 2
- FSLPMRQHCOLESF-UHFFFAOYSA-N alpha-amyrenol Natural products C1CC(O)C(C)(C)C2CCC3(C)C4(C)CCC5(C)CCC(C)C(C)C5C4=CCC3C21C FSLPMRQHCOLESF-UHFFFAOYSA-N 0.000 description 2
- 208000006673 asthma Diseases 0.000 description 2
- 230000003143 atherosclerotic effect Effects 0.000 description 2
- JFSHUTJDVKUMTJ-QHPUVITPSA-N beta-amyrin Chemical compound C1C[C@H](O)C(C)(C)[C@@H]2CC[C@@]3(C)[C@]4(C)CC[C@@]5(C)CCC(C)(C)C[C@H]5C4=CC[C@@H]3[C@]21C JFSHUTJDVKUMTJ-QHPUVITPSA-N 0.000 description 2
- QQFMRPIKDLHLKB-UHFFFAOYSA-N beta-amyrin Natural products CC1C2C3=CCC4C5(C)CCC(O)C(C)(C)C5CCC4(C)C3(C)CCC2(C)CCC1(C)C QQFMRPIKDLHLKB-UHFFFAOYSA-N 0.000 description 2
- PDNLMONKODEGSE-UHFFFAOYSA-N beta-amyrin acetate Natural products CC(=O)OC1CCC2(C)C(CCC3(C)C4(C)CCC5(C)CCC(C)(C)CC5C4=CCC23C)C1(C)C PDNLMONKODEGSE-UHFFFAOYSA-N 0.000 description 2
- 206010006451 bronchitis Diseases 0.000 description 2
- RYYVLZVUVIJVGH-UHFFFAOYSA-N caffeine Chemical compound CN1C(=O)N(C)C(=O)C2=C1N=CN2C RYYVLZVUVIJVGH-UHFFFAOYSA-N 0.000 description 2
- 235000012000 cholesterol Nutrition 0.000 description 2
- 235000013399 edible fruits Nutrition 0.000 description 2
- XTLWNMXYCHABQH-UHFFFAOYSA-N germanicol Natural products CC1(C)CCC2(C)CCC3(C)C(CCC4(C)C5(C)CCC(O)C(C)(C)C5CCC34C)C2=C1 XTLWNMXYCHABQH-UHFFFAOYSA-N 0.000 description 2
- 208000019622 heart disease Diseases 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- 208000004396 mastitis Diseases 0.000 description 2
- MRIAQLRQZPPODS-UHFFFAOYSA-N nobiletin Chemical compound C1=C(OC)C(OC)=CC=C1C1=CC(=O)C2=C(OC)C(OC)=C(OC)C(OC)=C2O1 MRIAQLRQZPPODS-UHFFFAOYSA-N 0.000 description 2
- 229920001277 pectin Polymers 0.000 description 2
- 235000010987 pectin Nutrition 0.000 description 2
- 239000001814 pectin Substances 0.000 description 2
- NGFFRJBGMSPDMS-UHFFFAOYSA-N psi-Taraxasterol Natural products CC12CCC(O)C(C)(C)C1CCC1(C)C2CCC2C3C(C)C(C)=CCC3(C)CCC21C NGFFRJBGMSPDMS-UHFFFAOYSA-N 0.000 description 2
- KZJWDPNRJALLNS-VJSFXXLFSA-N sitosterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CC[C@@H](CC)C(C)C)[C@@]1(C)CC2 KZJWDPNRJALLNS-VJSFXXLFSA-N 0.000 description 2
- 208000024794 sputum Diseases 0.000 description 2
- 210000003802 sputum Anatomy 0.000 description 2
- HCXVJBMSMIARIN-PHZDYDNGSA-N stigmasterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)/C=C/[C@@H](CC)C(C)C)[C@@]1(C)CC2 HCXVJBMSMIARIN-PHZDYDNGSA-N 0.000 description 2
- 229940032091 stigmasterol Drugs 0.000 description 2
- BFDNMXAIBMJLBB-UHFFFAOYSA-N stigmasterol Natural products CCC(C=CC(C)C1CCCC2C3CC=C4CC(O)CCC4(C)C3CCC12C)C(C)C BFDNMXAIBMJLBB-UHFFFAOYSA-N 0.000 description 2
- 235000016831 stigmasterol Nutrition 0.000 description 2
- 238000005728 strengthening Methods 0.000 description 2
- HUTYZQWCTWWXND-NCTFTGAASA-N taraxasterol Natural products C[C@H]1[C@H]2C3=CC[C@@H]4[C@@]5(C)CC[C@H](O)C(C)(C)[C@@H]5CC[C@@]4(C)[C@]3(C)C[C@H](O)[C@@]2(C)CCC1=C HUTYZQWCTWWXND-NCTFTGAASA-N 0.000 description 2
- GGGUGZHBAOMSFJ-GADYQYKKSA-N taraxerol Chemical compound CC([C@@H]1CC2)(C)[C@@H](O)CC[C@]1(C)[C@@H]1[C@]2(C)C2=CC[C@@]3(C)CCC(C)(C)C[C@H]3[C@]2(C)CC1 GGGUGZHBAOMSFJ-GADYQYKKSA-N 0.000 description 2
- HYTFUKZLSYXRDX-UHFFFAOYSA-N taraxerol Natural products CC1CCCC2C3(C)CCC4(C)C5CC(C)(C)CCC5(C)C=CC4(C)C3C(O)CC12C HYTFUKZLSYXRDX-UHFFFAOYSA-N 0.000 description 2
- 230000001225 therapeutic effect Effects 0.000 description 2
- 208000019206 urinary tract infection Diseases 0.000 description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 2
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 description 1
- 208000002874 Acne Vulgaris Diseases 0.000 description 1
- 201000004384 Alopecia Diseases 0.000 description 1
- 206010003011 Appendicitis Diseases 0.000 description 1
- 208000004300 Atrophic Gastritis Diseases 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- 206010006458 Bronchitis chronic Diseases 0.000 description 1
- 208000024172 Cardiovascular disease Diseases 0.000 description 1
- 201000004624 Dermatitis Diseases 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 206010015150 Erythema Diseases 0.000 description 1
- 208000001034 Frostbite Diseases 0.000 description 1
- 208000036495 Gastritis atrophic Diseases 0.000 description 1
- QUQPHWDTPGMPEX-UHFFFAOYSA-N Hesperidine Natural products C1=C(O)C(OC)=CC=C1C1OC2=CC(OC3C(C(O)C(O)C(COC4C(C(O)C(O)C(C)O4)O)O3)O)=CC(O)=C2C(=O)C1 QUQPHWDTPGMPEX-UHFFFAOYSA-N 0.000 description 1
- 235000003935 Hippophae Nutrition 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- 229920001202 Inulin Polymers 0.000 description 1
- LPHGQDQBBGAPDZ-UHFFFAOYSA-N Isocaffeine Natural products CN1C(=O)N(C)C(=O)C2=C1N(C)C=N2 LPHGQDQBBGAPDZ-UHFFFAOYSA-N 0.000 description 1
- 206010023126 Jaundice Diseases 0.000 description 1
- 208000003351 Melanosis Diseases 0.000 description 1
- 208000005647 Mumps Diseases 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- 201000007100 Pharyngitis Diseases 0.000 description 1
- 208000004880 Polyuria Diseases 0.000 description 1
- 208000001431 Psychomotor Agitation Diseases 0.000 description 1
- 206010037660 Pyrexia Diseases 0.000 description 1
- 206010038743 Restlessness Diseases 0.000 description 1
- 241000191967 Staphylococcus aureus Species 0.000 description 1
- 206010053615 Thermal burn Diseases 0.000 description 1
- 208000025865 Ulcer Diseases 0.000 description 1
- FPIPGXGPPPQFEQ-BOOMUCAASA-N Vitamin A Natural products OC/C=C(/C)\C=C\C=C(\C)/C=C/C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-BOOMUCAASA-N 0.000 description 1
- 206010000496 acne Diseases 0.000 description 1
- 201000004484 acute conjunctivitis Diseases 0.000 description 1
- 206010001093 acute tonsillitis Diseases 0.000 description 1
- 230000006978 adaptation Effects 0.000 description 1
- 230000032683 aging Effects 0.000 description 1
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 description 1
- 231100000360 alopecia Toxicity 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 230000004596 appetite loss Effects 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 229940076810 beta sitosterol Drugs 0.000 description 1
- NJKOMDUNNDKEAI-UHFFFAOYSA-N beta-sitosterol Natural products CCC(CCC(C)C1CCC2(C)C3CC=C4CC(O)CCC4C3CCC12C)C(C)C NJKOMDUNNDKEAI-UHFFFAOYSA-N 0.000 description 1
- 235000013361 beverage Nutrition 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 230000017531 blood circulation Effects 0.000 description 1
- 210000001124 body fluid Anatomy 0.000 description 1
- 239000010839 body fluid Substances 0.000 description 1
- 238000009835 boiling Methods 0.000 description 1
- 208000030303 breathing problems Diseases 0.000 description 1
- 229960001948 caffeine Drugs 0.000 description 1
- VJEONQKOZGKCAK-UHFFFAOYSA-N caffeine Natural products CN1C(=O)N(C)C(=O)C2=C1C=CN2C VJEONQKOZGKCAK-UHFFFAOYSA-N 0.000 description 1
- 235000014633 carbohydrates Nutrition 0.000 description 1
- 150000001720 carbohydrates Chemical class 0.000 description 1
- 208000026106 cerebrovascular disease Diseases 0.000 description 1
- 230000002279 cholagogic effect Effects 0.000 description 1
- 208000016644 chronic atrophic gastritis Diseases 0.000 description 1
- 208000007451 chronic bronchitis Diseases 0.000 description 1
- 230000001684 chronic effect Effects 0.000 description 1
- 206010009887 colitis Diseases 0.000 description 1
- 239000002131 composite material Substances 0.000 description 1
- 235000009508 confectionery Nutrition 0.000 description 1
- 238000012790 confirmation Methods 0.000 description 1
- 230000029087 digestion Effects 0.000 description 1
- 238000004821 distillation Methods 0.000 description 1
- 230000035619 diuresis Effects 0.000 description 1
- 230000002526 effect on cardiovascular system Effects 0.000 description 1
- 239000000839 emulsion Substances 0.000 description 1
- 239000002158 endotoxin Substances 0.000 description 1
- 230000003628 erosive effect Effects 0.000 description 1
- 231100000321 erythema Toxicity 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 230000003203 everyday effect Effects 0.000 description 1
- 230000004438 eyesight Effects 0.000 description 1
- 235000019197 fats Nutrition 0.000 description 1
- 239000003205 fragrance Substances 0.000 description 1
- 235000011389 fruit/vegetable juice Nutrition 0.000 description 1
- 208000003512 furunculosis Diseases 0.000 description 1
- 239000010437 gem Substances 0.000 description 1
- 229910001751 gemstone Inorganic materials 0.000 description 1
- 230000008821 health effect Effects 0.000 description 1
- 208000006454 hepatitis Diseases 0.000 description 1
- 231100000283 hepatitis Toxicity 0.000 description 1
- QUQPHWDTPGMPEX-QJBIFVCTSA-N hesperidin Chemical compound C1=C(O)C(OC)=CC=C1[C@H]1OC2=CC(O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@@H](CO[C@H]4[C@@H]([C@H](O)[C@@H](O)[C@H](C)O4)O)O3)O)=CC(O)=C2C(=O)C1 QUQPHWDTPGMPEX-QJBIFVCTSA-N 0.000 description 1
- 201000001421 hyperglycemia Diseases 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 210000000936 intestine Anatomy 0.000 description 1
- JYJIGFIDKWBXDU-MNNPPOADSA-N inulin Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)OC[C@]1(OC[C@]2(OC[C@]3(OC[C@]4(OC[C@]5(OC[C@]6(OC[C@]7(OC[C@]8(OC[C@]9(OC[C@]%10(OC[C@]%11(OC[C@]%12(OC[C@]%13(OC[C@]%14(OC[C@]%15(OC[C@]%16(OC[C@]%17(OC[C@]%18(OC[C@]%19(OC[C@]%20(OC[C@]%21(OC[C@]%22(OC[C@]%23(OC[C@]%24(OC[C@]%25(OC[C@]%26(OC[C@]%27(OC[C@]%28(OC[C@]%29(OC[C@]%30(OC[C@]%31(OC[C@]%32(OC[C@]%33(OC[C@]%34(OC[C@]%35(OC[C@]%36(O[C@@H]%37[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O%37)O)[C@H]([C@H](O)[C@@H](CO)O%36)O)[C@H]([C@H](O)[C@@H](CO)O%35)O)[C@H]([C@H](O)[C@@H](CO)O%34)O)[C@H]([C@H](O)[C@@H](CO)O%33)O)[C@H]([C@H](O)[C@@H](CO)O%32)O)[C@H]([C@H](O)[C@@H](CO)O%31)O)[C@H]([C@H](O)[C@@H](CO)O%30)O)[C@H]([C@H](O)[C@@H](CO)O%29)O)[C@H]([C@H](O)[C@@H](CO)O%28)O)[C@H]([C@H](O)[C@@H](CO)O%27)O)[C@H]([C@H](O)[C@@H](CO)O%26)O)[C@H]([C@H](O)[C@@H](CO)O%25)O)[C@H]([C@H](O)[C@@H](CO)O%24)O)[C@H]([C@H](O)[C@@H](CO)O%23)O)[C@H]([C@H](O)[C@@H](CO)O%22)O)[C@H]([C@H](O)[C@@H](CO)O%21)O)[C@H]([C@H](O)[C@@H](CO)O%20)O)[C@H]([C@H](O)[C@@H](CO)O%19)O)[C@H]([C@H](O)[C@@H](CO)O%18)O)[C@H]([C@H](O)[C@@H](CO)O%17)O)[C@H]([C@H](O)[C@@H](CO)O%16)O)[C@H]([C@H](O)[C@@H](CO)O%15)O)[C@H]([C@H](O)[C@@H](CO)O%14)O)[C@H]([C@H](O)[C@@H](CO)O%13)O)[C@H]([C@H](O)[C@@H](CO)O%12)O)[C@H]([C@H](O)[C@@H](CO)O%11)O)[C@H]([C@H](O)[C@@H](CO)O%10)O)[C@H]([C@H](O)[C@@H](CO)O9)O)[C@H]([C@H](O)[C@@H](CO)O8)O)[C@H]([C@H](O)[C@@H](CO)O7)O)[C@H]([C@H](O)[C@@H](CO)O6)O)[C@H]([C@H](O)[C@@H](CO)O5)O)[C@H]([C@H](O)[C@@H](CO)O4)O)[C@H]([C@H](O)[C@@H](CO)O3)O)[C@H]([C@H](O)[C@@H](CO)O2)O)[C@@H](O)[C@H](O)[C@@H](CO)O1 JYJIGFIDKWBXDU-MNNPPOADSA-N 0.000 description 1
- 229940029339 inulin Drugs 0.000 description 1
- 239000008141 laxative Substances 0.000 description 1
- 230000002475 laxative effect Effects 0.000 description 1
- 229920006008 lipopolysaccharide Polymers 0.000 description 1
- 235000021266 loss of appetite Nutrition 0.000 description 1
- 208000019017 loss of appetite Diseases 0.000 description 1
- 210000004072 lung Anatomy 0.000 description 1
- 201000007227 lymph node tuberculosis Diseases 0.000 description 1
- 239000002075 main ingredient Substances 0.000 description 1
- 206010025482 malaise Diseases 0.000 description 1
- 230000003211 malignant effect Effects 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 208000010805 mumps infectious disease Diseases 0.000 description 1
- 230000000050 nutritive effect Effects 0.000 description 1
- 150000007524 organic acids Chemical class 0.000 description 1
- 239000002304 perfume Substances 0.000 description 1
- 230000002085 persistent effect Effects 0.000 description 1
- 239000000049 pigment Substances 0.000 description 1
- 231100000614 poison Toxicity 0.000 description 1
- 150000008442 polyphenolic compounds Chemical class 0.000 description 1
- 235000013824 polyphenols Nutrition 0.000 description 1
- 230000003449 preventive effect Effects 0.000 description 1
- 235000018102 proteins Nutrition 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 238000010791 quenching Methods 0.000 description 1
- 230000005855 radiation Effects 0.000 description 1
- 210000002345 respiratory system Anatomy 0.000 description 1
- 238000005070 sampling Methods 0.000 description 1
- 229950005143 sitosterol Drugs 0.000 description 1
- 235000014347 soups Nutrition 0.000 description 1
- 235000013599 spices Nutrition 0.000 description 1
- 210000000952 spleen Anatomy 0.000 description 1
- 230000001954 sterilising effect Effects 0.000 description 1
- 210000002784 stomach Anatomy 0.000 description 1
- 238000007920 subcutaneous administration Methods 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- YRCWQPVGYLYSOX-UHFFFAOYSA-N synephrine Chemical compound CNCC(O)C1=CC=C(O)C=C1 YRCWQPVGYLYSOX-UHFFFAOYSA-N 0.000 description 1
- 229940026510 theanine Drugs 0.000 description 1
- 230000035922 thirst Effects 0.000 description 1
- 239000003440 toxic substance Substances 0.000 description 1
- 239000003053 toxin Substances 0.000 description 1
- 231100000765 toxin Toxicity 0.000 description 1
- 235000013619 trace mineral Nutrition 0.000 description 1
- 239000011573 trace mineral Substances 0.000 description 1
- 230000002936 tranquilizing effect Effects 0.000 description 1
- 231100000397 ulcer Toxicity 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 235000019155 vitamin A Nutrition 0.000 description 1
- 239000011719 vitamin A Substances 0.000 description 1
- 229940045997 vitamin a Drugs 0.000 description 1
- 150000003722 vitamin derivatives Chemical class 0.000 description 1
- 210000004916 vomit Anatomy 0.000 description 1
- 230000008673 vomiting Effects 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23F—COFFEE; TEA; THEIR SUBSTITUTES; MANUFACTURE, PREPARATION, OR INFUSION THEREOF
- A23F3/00—Tea; Tea substitutes; Preparations thereof
- A23F3/06—Treating tea before extraction; Preparations produced thereby
- A23F3/14—Tea preparations, e.g. using additives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
- A61K36/285—Aucklandia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
- A61K36/288—Taraxacum (dandelion)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/75—Rutaceae (Rue family)
- A61K36/752—Citrus, e.g. lime, orange or lemon
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/82—Theaceae (Tea family), e.g. camellia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
- A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Pharmacology & Pharmacy (AREA)
- Botany (AREA)
- Alternative & Traditional Medicine (AREA)
- Biotechnology (AREA)
- Medical Informatics (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Non-Alcoholic Beverages (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
治疗慢性胃炎的养生中药茶饮品及制备方法，其主要原料及重量份分别是，蒲公英10份、木香8份、沙棘7份、陈皮5份、绿茶5份。本发明所述中药茶饮品的制备方法为以下步骤：步骤一）、称取原料蒲公英10份、木香8份、沙棘7份、陈皮5份，经过高压锅蒸煮杀菌20-30分钟，晾干并研成粗末，获得无菌原材料；步骤二）、所获得的无菌原材料，加入绿茶5份混合，即获得养生中药茶饮品。养生中药茶饮品的有益效果：有轻微中药香味，无任何毒副作用，清热和中、行气止痛效果明显，用于治疗慢性胃炎、浅表性胃炎、胃及十二指肠溃疡、胃脘胀痛、消化不良、大便不畅病症。
Description
技术领域
本发明涉及一种中药茶领域，具体涉及由中药原料与茶配伍制成的养生中药茶饮品及制备方法。
背景技术
药茶是在茶叶中添加食物或药物制作而成的具一定疗效的特殊的液体饮料。广义的药茶还包括不含茶叶，由食物和药物经冲泡、煎煮、压榨及蒸馏等方法制作而成的代茶饮用品，如汤饮、鲜汁、露剂、乳剂等。中医中药是中华民族中的一座宝库，食疗是这座宝库中的一顶皇冠，而茶疗恰恰是这顶皇冠上那颗最耀眼的明珠。药茶将药与茶完美结合，能防疾病，能品茶趣，常饮能祛顽疾、强体魄、安心神、润喉肠、降脂减肥、益寿延年。药茶是根植于中医药文化与茶文化基础之上的一种养生方式，真正意义上的药茶是以中药原植物叶片，并结合中药与茶叶炮制方法，制作成茶叶形态，它同时具备中药的治疗养生效果与茶叶的“形、色、香、道”，具有实效性、安全性、享受性及便捷性四大优点。
发明内容
本发明的目的在于提供一种具有清热和中、行气止痛功效的养生中药茶饮品及制备方法，对慢性胃炎、浅表性胃炎、胃及十二指肠溃疡、胃脘胀痛、消化不良、大便不畅具有良好的预防和治疗作用。
本发明采用的技术方案在于：所述养生中药茶饮品及制备方法，其主要原料及重量份分别是，蒲公英10份、木香8份、沙棘7份、陈皮5份、绿茶5份。
本发明所述养生中药茶饮品的制备方法为以下步骤：
步骤一）、称取原料蒲公英10份、木香8份、沙棘7份、陈皮5份，经过高压锅蒸煮杀菌20-30分钟，晾干并研成粗末，获得无菌原材料；
步骤二）、所获得的无菌原材料，加入绿茶5份混合，即获得养生中药茶饮品。
本发明所选择的原料，其药性和功效分别是：
蒲公英：属菊科多年生草本植物。蒲公英植物体中含有蒲公英醇、蒲公英素、胆碱、有机酸、菊糖等多种健康营养成分，有利尿、缓泻、退黄疸、利胆等功效。蒲公英同时含有蛋白质、脂肪、碳水化合物、微量元素及维生素等，有丰富的营养价值。【性味功能】：甘，微苦，寒。清热解毒，消肿散结。【主治】：上呼吸道感染，眼结膜炎，流行性腮腺炎，高血糖，乳痈肿痛，胃炎，痢疾，肝炎，胆襄炎，急性阑尾炎，泌尿系感染，盆腔炎，痈疖疔疮，咽炎，治急性乳腺炎，淋巴腺炎，瘰疠，疔毒疮肿，急性结膜炎，感冒发热，急性扁桃体炎，急性支气管炎、尿路感染。含蒲公英甾醇（Taraxasterol）、胆碱（Choline）、菊糖（Inulin）、果胶（Pectin）；蒲公英醇（Taraxol）、豆甾醇（Stigmasterol）、β-香树脂醇（β-Amyrin）、β-谷甾醇（β-Sitosterol）、蒲公英赛醇（taraxerol）、蒲公英素（Taraxacerin）、蒲公英苦素（Taraxacin）和维生素A、B、C等。蒲公英功效与作用在药用价值上尤其能体现出来，其不但可以治疗白发，还有保护皮肤，防治脸上起红疹，色素，雀斑等作用。可见蒲公英的作用非同小可。无论你是老化皮肤，或是干油性皮肤，无论是脱发、痤疮、皮肤炎等，蒲公英都能帮助你解决他们，消灭他们。另外，杀菌也是蒲公英的一大功效。它对金黄色葡萄球耐药菌株有着很强杀菌作用。在临床上也广泛的被使用于各种呼吸道疾病和肠胃炎中。
木香：【功效分类】：理气药；行气药；温里药。【功效】：行气止痛；调中导滞。【主治】：胞胁胀满足；脘腹胀痛；哎吐泄泻；痢疾后重。
沙棘：胡颓子科植物沙棘HippophaerhamnoidesL.的干燥成熟果实。沙棘果实入药具有止咳化痰、健胃消食、活血散瘀之功效。现代医学研究，沙棘可降低胆固醇，缓解心绞痛发作，还有防治冠状动脉粥样硬化性心脏病的作用。沙棘果具有很高的药用价值，可降低胆固醇，缓解心绞痛发作，还有防治冠状动脉粥样硬化性心脏病的作用；有祛痰、止咳、平喘和治疗慢性气管炎的作用；能治疗胃和十二指肠溃疡以及消化不良等，对慢性浅表性胃炎、萎缩性胃炎、结肠炎等病症疗效显著；对烧伤、烫伤、刀烧、冻伤有很好的治疗作用；对妇女宫颈糜烂有良好的治疗效果。
陈皮：陈皮含橙皮甙约8.4%,川陈皮素（nobiletin）约0。15%．另含辛弗林（对羟福林）0.28%-2。54%。【主治功效】：理气健脾，调中，燥湿，化痰。主治脾胃气滞之脘腹胀满或疼痛、消化不良。湿浊阻中之胸闷腹胀、纳呆便溏。痰湿壅肺之咳嗽气喘。用于胸脘胀满，食少吐泻，咳嗽痰多。
绿茶：绿茶的功效与作用：茶是健康之液，灵魂之饮。在我国被誉为“国饮”。现代科学大量研究证实，茶叶确实含有与人体健康密切相关的生化成份，茶叶不仅具有提神清心、清热解暑、消食化痰、去腻减肥、清心除烦、解毒醒酒、生津止渴、降火明目、止痢除湿等药理作用，还对现代疾病，如辐射病、心脑血管病、癌症等疾病，有一定的药理功效。茶叶具有药理作用的主要成份是茶多酚、咖啡碱、脂多糖、茶氨酸等。
本发明中药茶饮品的清热和中、行气止痛功效在临床应用当中得到了证实，基本资料如下：2005-2013年，门诊临床应用本发明所述养生中药茶饮品对452例体验者用；有慢性胃炎、浅表性胃炎、胃及十二指肠溃疡、胃脘胀痛、消化不良、大便不畅病症，平均年龄35岁；服用方法：开水冲饮，每日早晚饮用200-250ml；连续服用21-28日后，有效或显效387例；有效或显效的评价标准为：症状有所改善或者症状消失。
本发明养生中药茶饮品的有益效果：有轻微中药香味，无任何毒副作用，清热和中、行气止痛效果明显，用于治疗慢性胃炎、浅表性胃炎、胃及十二指肠溃疡、胃脘胀痛、消化不良、大便不畅病症。
具体实施方法
所述治疗慢性胃炎的养生中药茶饮品及制备方法，其主要原料及重量份分别是，蒲公英10份、木香8份、沙棘7份、陈皮5份、绿茶5份。
本发明所述中药茶饮品的制备方法为以下步骤：
步骤一）、称取原料蒲公英10份、木香8份、沙棘7份、陈皮5份，经过高压锅蒸煮杀菌20-30分钟，晾干并研成粗末，获得无菌原材料；
步骤二）、所获得的无菌原材料，加入绿茶5份混合，即获得养生中药茶饮品。
Claims (2)
1.一种治疗慢性胃炎的养生中药茶饮品，其特征在于，其主要原料及重量份分别是，蒲公英10份、木香8份、沙棘7份、陈皮5份、绿茶5份。
2.按照权利要求1所述的中药茶饮品，其特征在于，制备方法为以下步骤：
步骤一）、称取原料蒲公英10份、木香8份、沙棘7份、陈皮5份，经过高压锅蒸煮杀菌20-30分钟，晾干并研成粗末，获得无菌原材料；
步骤二）、所获得的无菌原材料，加入绿茶5份混合，即获得养生中药茶饮品。
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201510959567.6A CN105494742A (zh) | 2015-12-21 | 2015-12-21 | 治疗慢性胃炎的养生中药茶饮品及制备方法 |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201510959567.6A CN105494742A (zh) | 2015-12-21 | 2015-12-21 | 治疗慢性胃炎的养生中药茶饮品及制备方法 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN105494742A true CN105494742A (zh) | 2016-04-20 |
Family
ID=55703352
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201510959567.6A Pending CN105494742A (zh) | 2015-12-21 | 2015-12-21 | 治疗慢性胃炎的养生中药茶饮品及制备方法 |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN105494742A (zh) |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN106234673A (zh) * | 2016-07-10 | 2016-12-21 | 侯春华 | 益胃养生中药茶饮品及制备方法 |
| CN114558071A (zh) * | 2022-03-29 | 2022-05-31 | 赣南医学院 | 一种用于护胃的中药组合物及制备方法、包含该中药组合物的制剂 |
-
2015
- 2015-12-21 CN CN201510959567.6A patent/CN105494742A/zh active Pending
Non-Patent Citations (3)
| Title |
|---|
| 冷方南主编: "《中国基本中成药（二部 附：保健药品分册）》", 30 July 1991, 人民卫生出版社出版社 * |
| 李洁编著: "《茶问健康：茶疗速查手册》", 31 December 2010, 商务印书馆国际有限公司 * |
| 林傲梵等主编: "《胃肠病防治与用药198问》", 30 June 2013, 人民军医出版社 * |
Cited By (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN106234673A (zh) * | 2016-07-10 | 2016-12-21 | 侯春华 | 益胃养生中药茶饮品及制备方法 |
| CN114558071A (zh) * | 2022-03-29 | 2022-05-31 | 赣南医学院 | 一种用于护胃的中药组合物及制备方法、包含该中药组合物的制剂 |
| CN114558071B (zh) * | 2022-03-29 | 2023-11-24 | 赣南医学院 | 一种用于护胃的中药组合物及制备方法、包含该中药组合物的制剂 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN105494742A (zh) | 治疗慢性胃炎的养生中药茶饮品及制备方法 | |
| CN104397231A (zh) | 荸荠养生中药茶饮品及制备方法 | |
| CN104397240A (zh) | 石斛瓜蒌养生中药茶饮品及制备方法 | |
| CN104286264A (zh) | 灵芝养生中药茶饮品及制备方法 | |
| CN104397236A (zh) | 平胃养生中药茶饮品及制备方法 | |
| CN104824229A (zh) | 蒲公英金银花养生中药茶饮品及制备方法 | |
| CN104286257A (zh) | 茯苓奶茶养生中药茶饮品及制备方法 | |
| CN104872315A (zh) | 润肺下气止咳养生中药茶饮品及制备方法 | |
| CN104800621A (zh) | 一种预防高血压的保健粥及制备方法 | |
| CN105707253A (zh) | 一种南烛子强筋明目奶茶及其生产方法 | |
| CN104397237A (zh) | 清热和胃养生中药茶饮品及制备方法 | |
| CN104397238A (zh) | 清肺益胃养生中药茶饮品及制备方法 | |
| CN104824222A (zh) | 桑菊竹养生中药茶饮品及制备方法 | |
| CN106234673A (zh) | 益胃养生中药茶饮品及制备方法 | |
| CN104304545A (zh) | 陈皮茯苓养生中药茶饮品及制备方法 | |
| CN104855608A (zh) | 疏风清热养生中药茶饮品及制备方法 | |
| CN105639010A (zh) | 一种秘茶饮料及加工方法 | |
| CN104304540A (zh) | 荷叶山楂养生中药茶饮品及制备方法 | |
| CN104273262A (zh) | 芝麻养生中药茶饮品及制备方法 | |
| CN104543085A (zh) | 一种降香舒心降脂茶的配方及生产方法 | |
| CN104351385A (zh) | 解毒消肿养生中药茶饮品及制备方法 | |
| CN104824218A (zh) | 桑菊杏仁养生中药茶饮品及制备方法 | |
| CN105707259A (zh) | 一种紫石英镇心安神奶茶及其生产方法 | |
| CN104397241A (zh) | 人参甘草养生中药茶饮品及制备方法 | |
| CN104845860A (zh) | 温经补脾益肾生精柿子醋 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| WD01 | Invention patent application deemed withdrawn after publication |
Application publication date: 20160420 |
|
| WD01 | Invention patent application deemed withdrawn after publication |